NCT01161654CompletedNot Applicable
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fed Conditions
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Roxane Laboratories
- Enrollment
- 33
- Locations
- 1
- Primary Endpoint
- bioequivalence determined by statistical comparison Cmax
Study Overview
Brief Summary
The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride Tablet under fed conditions.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening
Exclusion Criteria
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to naratriptan hydrochloride or any comparable or similar product.
Outcomes
Primary Outcomes
bioequivalence determined by statistical comparison Cmax
Time Frame: 9 days
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted ConditionsMigraineNCT01161667Roxane Laboratories35
Withdrawn
Phase 3
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of MigraineHeadacheMigraineNCT01390324Ache Laboratorios Farmaceuticos S.A.
Completed
Not Applicable
Bioequivalency Study of Terbinafine Tablets Under Fasting ConditionsOnychomycosisNCT00602342Roxane Laboratories30
Completed
Not Applicable
Bioequivalency Study of Terbinafine Tablets Under Fed ConditionsOnychomycosisNCT00602251Roxane Laboratories30
Completed
Not Applicable
Bioequivalency Study of Sertraline Under Fasting ConditionsDepressionNCT00602849Roxane Laboratories38